MUC16 and neoplasm: The tumor staining of CA125 was significantly higher in mice with terminated paclitaxel compared to the paclitaxel group in Phase 1; but remained unchanged between the paclitaxel+momelotinib groups in Phase 2 and Phase 1 studies (Supplementary Figure 9).